Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Korean Medical Science ; : 146-151, 2009.
Artigo em Inglês | WPRIM | ID: wpr-8098

RESUMO

This study was designed to determine whether early gabapentin treatment has a protective analgesic effect on neuropathic pain and compared its effect to the late treatment in a rat neuropathic model, and as the potential mechanism of protective action, the alpha2delta1-subunit of the voltage-dependent calcium channel (alpha2delta1-subunit) was evaluated in both sides of the L5 dorsal root ganglia (DRG). Neuropathic pain was induced in male Sprague-Dawley rats by a surgical ligation of left L5 nerve. For the early treatment group, rats were injected with gabapentin (100 mg/kg) intraperitoneally 15 min prior to surgery and then every 24 hr during postoperative day (POD) 1-4. For the late treatment group, the same dose of gabapentin was injected every 24 hr during POD 8-12. For the control group, L5 nerve was ligated but no gabapentin was administered. In the early treatment group, the development of allodynia was delayed up to POD 10, whereas allodynia was developed on POD 2 in the control and the late treatment group (p<0.05). The alpha2delta1-subunit was up-regulated in all groups, however, there was no difference in the level of the alpha2delta1-subunit among the three groups. These results suggest that early treatment with gabapentin offers some protection against neuropathic pain but it is unlikely that this action is mediated through modulation of the alpha2delta1-subunit in DRG.


Assuntos
Animais , Masculino , Ratos , Aminas/administração & dosagem , Analgésicos/administração & dosagem , Canais de Cálcio/genética , Ácidos Cicloexanocarboxílicos/administração & dosagem , Modelos Animais de Doenças , Injeções Intraperitoneais , Ligadura , Neuralgia/tratamento farmacológico , Medição da Dor , Subunidades Proteicas/genética , Ratos Sprague-Dawley , Nervos Espinhais/cirurgia , Regulação para Cima , Ácido gama-Aminobutírico/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA